What is the recommended Pap smear surveillance schedule for a patient post-Loop Electrosurgical Excision Procedure (LEEP)?

Post-LEEP Pap Surveillance Schedule

After LEEP treatment for CIN II or III, perform cervical cytology at 6-month intervals or HPV DNA testing at 12 months, and continue surveillance for at least 25 years even if this extends beyond age 65. 1

Initial Post-Treatment Surveillance

The surveillance strategy depends on the margin status of your LEEP specimen:

For Negative Margins (CIN II or III) or All CIN I Lesions

• Perform cervical cytology at 6 months OR HPV DNA testing at 12 months 1
• If using cytology alone, test at 6,12,18,24, and 30 months 1
• If using HPV testing or co-testing, perform at 6,18, and 30 months 1

For Positive Margins (CIN II or III)

You have three management options 1:

1. Cervical cytology at 6 months (endocervical curettage can be considered as category 2B)
2. Reexcision, especially if invasion is suspected
3. Consider hysterectomy

Return to Routine Screening Criteria

If surveillance testing is negative:

• Resume regular screening guidelines after completing initial surveillance 1
• However, this does NOT mean stopping surveillance at standard ages

If surveillance testing is positive:

• HPV DNA positive → proceed to colposcopy 1
• Cytology showing ASC-US or greater → follow standard screening management recommendations 1

Long-Term Surveillance Requirements

Critical caveat: After treatment for high-grade precancer (CIN II or III), surveillance must continue for at least 25 years, even if this extends beyond age 65 1. This is a major exception to standard cervical cancer screening cessation guidelines.

Long-term surveillance schedule:

• Every 3 years if using HPV testing or co-testing 1
• Annually if using cytology testing alone 1

If hysterectomy occurs during surveillance:

• Continue vaginal screening throughout the 25-year surveillance period 1

Common Pitfalls to Avoid

Do not discontinue surveillance at age 65 in women with a history of CIN II or III treatment—this is the most critical error to avoid. These women remain at elevated risk and require extended surveillance regardless of age 1, 2.

Recognize post-LEEP cytologic artifacts: LEEP procedures create thermal artifacts including "taffy-pulled" nuclei, coalesced cytoplasm, hockey stick nuclei, and smudgy chromatin that can complicate interpretation 3. These features are procedure-related and should not be misinterpreted as dysplasia.

Monitor for cervical stenosis: Absent endocervical cells on post-LEEP Pap smears occur in approximately 13.6% of cases (compared to 7% baseline) and may indicate cervical stenosis 4. This is significantly associated with LEEP procedures and may affect adequacy of surveillance.

Ensure adequate follow-up occurs: Studies show that in approximately 7% of cases, no cytological or histological follow-up occurs within one year of abnormal results 5. Establish robust tracking systems to prevent loss to follow-up.